title: Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.
abstract: The thyroid hormone, 3, 3',5-triiodo-l-thyronine (T(3)), regulates cell growth, development, differentiation, and metabolism via interactions with thyroid hormone receptors (TRs). However, the secreted proteins that are regulated by T(3) are yet to be characterized. In this study, we used the quantitative proteomic approach of stable isotope labeling with amino acids in cell culture coupled with nano-liquid chromatography-tandem MS performed on a LTQ-Orbitrap instrument to identify and characterize the T(3)-regulated proteins secreted in human hepatocellular carcinoma cell lines overexpressing TRα1 (HepG2-TRα1). In total, 1742 and 1714 proteins were identified and quantified, respectively, in three independent experiments. Among these, 61 up-regulated twofold and 11 down-regulated twofold proteins were identified. Eight proteins displaying increased expression and one with decreased expression in conditioned media were validated using Western blotting. Real-time quantitative RT-PCR further disclosed induction of plasminogen activator inhibitor-1 (PAI-1), a T(3) target, in a time-course and dose-dependent manner. Serial deletions of the PAI-1 promoter region and subsequent chromatin immunoprecipitation assays revealed that the thyroid hormone response element on the promoter is localized at positions -327/-312. PAI-1 overexpression enhanced tumor growth and migration in a manner similar to what was seen when T(3) induced PAI-1 expression in J7-TRα1 cells, both in vitro and in vivo. An in vitro neutralizing assay further supported a crucial role of secreted PAI-1 in T(3)/TR-regulated cell migration. To our knowledge, these results demonstrate for the first time that proteins involved in the urokinase plasminogen activator system, including PAI-1, uPAR, and BSSP4, are augmented in the extra- and intracellular space of T(3)-treated HepG2-TRα1 cells. The T(3)-regulated secretome generated in the current study may provide an opportunity to establish the mechanisms underlying T(3)-associated tumor progression and prognosis.
authors.affiliation: Department of Biochemistry, School of Medicine, Chang-Gung University, Taoyuan, Taiwan 333.
authors.forename: Cheng-Yi
authors.initials: CY
authors.lastname: Chen
authors.forename: Lang-Ming
authors.initials: LM
authors.lastname: Chi
authors.forename: Hsiang-Cheng
authors.initials: HC
authors.lastname: Chi
authors.forename: Ming-Ming
authors.initials: MM
authors.lastname: Tsai
authors.forename: Chung-Ying
authors.initials: CY
authors.lastname: Tsai
authors.forename: Yi-Hsin
authors.initials: YH
authors.lastname: Tseng
authors.forename: Yang-Hsiang
authors.initials: YH
authors.lastname: Lin
authors.forename: Wei-Jan
authors.initials: WJ
authors.lastname: Chen
authors.forename: Ya-Hui
authors.initials: YH
authors.lastname: Huang
authors.forename: Kwang-Huei
authors.initials: KH
authors.lastname: Lin
mesh_terms: D000596:Amino Acids; D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D002465:Cell Movement; D002853:Chromatography, Liquid; D006801:Humans; D007553:Isotope Labeling; D008113:Liver Neoplasms / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051379:Mice; D008819:Mice, Nude; D016513:Mice, SCID; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000378:metabolism; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics / Q000378:metabolism*; D020543:Proteome / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D053719:Tandem Mass Spectrometry; D014284:Triiodothyronine / Q000378:metabolism*; D047368:Tumor Burden
chemical_list: D000596:Amino Acids; D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D017395:Plasminogen Activator Inhibitor 1; D020543:Proteome; C051321:SERPINE1 protein, human; D014284:Triiodothyronine